The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy
Abstract
Objective Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer (PLC) arising from intrahepatic bile ducts. We carried out a case-control study to assess the association between ICC and hepatitis B and C virus (HBV and HCV) infections, alcohol intake, and hepatolithiasis in Brescia, North Italy. Methods Among 370 subjects with histology-based diagnosis of PLC who were resident in the area and hospitalized in 1995-2000, 26 (7%) ICC cases were identified. A total of 824 subjects unaffected by hepatic diseases and frequency-matched with PLC cases by age, sex, date, and hospital of admission were recruited as controls. Results Among ICC cases the mean age was 65 years, 80.8% were males, and 38.5% had cirrhosis. Seropositivity for anti-HCV, HBsAg, alcohol intake >80 g/day and history of hepatolithiasis were found in 25%, 13%, 23.1%, and 26.9% of ICC cases and in 5.8%, 6.7%, 32.9%, and 10.6% of controls, respectively. The odds ratios adjusted for demographic factors by logistic regression (95% confidence interval; 95% CI) were 9.7 (1.6-58.9) for anti-HCV, 2.7 (0.4-18.4) for HBsAg, and 6.7 (1.3-33.4) for hepatolithiasis, whereas no association was found with alcohol drinking. Conclusions HCV and hepatolithiasis may be risk factors for ICC in Western countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Major risk factors for cholangiocarcinoma also vary by region and include liver flukes (e.g., in the northeast region of Thailand, where Opisthorchis viverrini, is endemic) 121 and metabolic conditions (including obesity, diabetes, and nonalcoholic fatty liver disease), alongside heavy alcohol consumption and HBV and HCV infections.122-124”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [124]
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
IARC monographs on the evaluation of carcinogenic risks to humans
Hopkins, J. (1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90054-9 · Cited by 2,876
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., & Nagorney, D. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411807 · Cited by 955
Fine, H. A., Dear, K. B. G., Loeffler, J. S., Black, P. M., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1 · Cited by 861
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Bostwick, D. G., Pacelli, A., Blute, M., Roche, P., & Murphy, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2256::aid-cncr22>3.0.co;2-s · Cited by 698
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
[Epidemiology of hepatocellular carcinoma].
Rosellini, S. R., & Miglio, F. (1991) · PubMed · Cited by 326
Attili, A. F., Carulli, N., Roda, E., Barbara, B., Capocaccia, L., Menotti, A., Okoliksanyi, L., Ricci, G., Capocaccia, R., Festi, D., et al. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117403 · Cited by 294
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Thyroid cancer in an iodide rich area. A histopathological study
Williams, E. D., Doniach, I., Bjarnason, O., & Michie, W. (1977) · Cancer · doi:10.1002/1097-0142(197701)39:1<45::aid-cncr2820390109>3.0.co;2-t · Cited by 275
Okuda, K., Kubo, Y., Okazaki, N., Arishima, T., Hashimoto, M., Jinnouchi, S., Sawa, Y., Shimokawa, Y., Nakajima, Y., Noguchi, T., et al. (1977) · Cancer · doi:10.1002/1097-0142(197701)39:1<232::aid-cncr2820390137>3.0.co;2-y · Cited by 261
Pineal parenchymal tumors: Clinical, pathologic, and therapeutic aspects
Schild, S. E., Scheithauer, B. W., Schomberg, P. J., Hook, C. C., Kelly, P. J., Frick, L., Robinow, J. S., & Buskirk, S. J. (1993) · Cancer · doi:10.1002/1097-0142(19930801)72:3<870::aid-cncr2820720336>3.0.co;2-x · Cited by 247
Kobayashi, M., Ikeda, K., Saitoh, S., Suzuki, F., Tsubota, A., Suzuki, Y., Arase, Y., Murashima, N., Chayama, K., & Kumada, H. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2471::aid-cncr7>3.0.co;2-t · Cited by 247
SHIN, H.-R., LEE, C.-U., PARK, H.-J., SEOL, S.-Y., CHUNG, J.-M., CHOI, H.-C., AHN, Y.-O., & SHIGEMASTU, T. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.5.933 · Cited by 237
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
Self-citationLiver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Parkin, D. M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
Parkin, D. M., Ohshima, H., Srivatanakul, P., & Vatanasapt, V. (1993) · PubMed · Cited by 187
Haenel, H. (1989) · Food / Nahrung · doi:10.1002/food.19890331018 · Cited by 186
Hardell, L., Bengtsson, N. O., Jonsson, U., Eriksson, S., & Larsson, L. G. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.188 · Cited by 183
Hepatolithiasis associated with cholangiocarcinoma
Kubo, S., Kinoshita, H., Hirohashi, K., & Hamda, H. (1995) · World Journal of Surgery · doi:10.1007/bf00294744 · Cited by 177
Tagger, A., Donato, F., Ribero, M. L., Chiesa, R., Portera, G., Gelatti, U., Albertini, A., Fasola, M., Boffetta, P., Nardi, G., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990531)81:5<695::aid-ijc4>3.0.co;2-w · Cited by 158
Self-citationPrimary sclerosing cholangitis: Liver transplantation or biliary surgery
Farges, O., Malassagne, B., Sebagh, M., & Bismuth, H. (1995) · Surgery · doi:10.1016/s0039-6060(05)80078-9 · Cited by 147
Are hepatolithiasis and cholangiocarcinoma aetiologically related?
Nakanuma, Y., Terada, T., Tanaka, Y., et al. (1985) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00710556 · Cited by 145
Kornfeld, D., Ekbom, A., & Ihre, T. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011222 · Cited by 132
Hepatolithiasis associated with cholangiocarcinoma
Su, C.-H., Ym, S., Lui, W., et al. (1997) · British journal of surgery · doi:10.1002/bjs.1800840717 · Cited by 124
A reappraisal of cholangiocarcinoma in patient with hepatolithiasis
Chen, M.-F., Jan, Y.-Y., Wang, C., Hwang, T., Jeng, L.-B., Chen, S., & Chen, T. (1993) · Cancer · Cited by 124
Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma
Altaee, M. Y., Johnson, P. J., Farrant, J. M., & Williams, R. L. (1991) · Cancer · Cited by 123
Risk factors in primary sclerosing cholangitis
Schrumpf, E., Abdelnoor, M., FAUSA, O., Elgjo, K., Jenssen, E., & Kolmannskog, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80618-x · Cited by 122
Okolicsànyi, L., Fabris, L., Viaggi, S., Carulli, N., Podda, M., & Ricci, G. (1996) · PubMed · Cited by 120
The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy
Morrow, G. R. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2766::aid-cncr2820551207>3.0.co;2-7 · Cited by 115
Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinoma
Holzinger, F., Z’graggen, K., & Büchler, M. W. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s122 · Cited by 110
Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance
Koga, A., Ichimiya, H., Yamaguchi, K., Miyazaki, K., & Nakayama, F. (1985) · Cancer · Cited by 108
Tomimatsu, M., Ishiguro, N., Taniai, M., Okuda, H., Saito, A., Obata, H., Yamamoto, M., Takasaki, K., & Nakano, M. (1993) · Cancer · Cited by 107
Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
Chijiiwa, K., Ichimiya, H., Kuroki, S., et al. (1993) · PubMed · Cited by 80
Minute nodular intrahepatic cholangiocarcinoma.
Yamamoto, M., Takasaki, K., Nakano, M., et al. (1998) · PubMed · Cited by 72
Cognitive function in children with leukemia. Effect of radiation dose and time since irradiation
Moore, I. M., Kramer, J. H., Wara, W. M., Halberg, F. E., & Ablin, A. R. (1991) · Cancer · doi:10.1002/1097-0142(19911101)68:9<2064::aid-cncr2820680937>3.0.co;2-3 · Cited by 71
Minute nodular intrahepatic cholangiocarcinoma
Yamamoto, M., Takasaki, K., Nakano, M., & Saito, A. (1998) · Cancer · Cited by 59
Kaczynski, J., Hansso, G., & Wallerstedt, S. (1998) · Acta Oncologica · doi:10.1080/028418698423212 · Cited by 51
Onier, N., Hilpert, S., Reveneau, S., Arnould, L., Saint-Giorgio, V., Exbrayat, J., & Jeannin, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990531)81:5<726::aid-ijc10>3.0.co;2-q · Cited by 43
Intrahepatic cholangiocarcinoma in Taiwan
Chen, M., Jan, Y.-Y., Jeng, L., et al. (1999) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050096 · Cited by 39
Songsivilai, S., Dharakul, T., & Kanistanon, D. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90296-5 · Cited by 27
Chiesa, R., Donato, F., Portolani, N., et al. (1995) · European Journal of Epidemiology · doi:10.1007/bf01721229 · Cited by 16
Self-citation
Research works printed but not linked: 6
- Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F (1985) Hepatolithiasis associated with cholangiocarcinoma. Cancer 55: 2826-2829. · doi:10.1002/1097-0142(19850615)55:12<2826::aid-cncr2820551219>3.0.co;2-1
- Corrao G, Busellu G, Valenti M, et al. (1994) Reproducibility of measuring lifetime alcohol consumption by a simple interviewadministered questionnaire. Alcologia 6: 127-135.
- Rothman KJ (1986) Modern Epidemiology. Boston, MA: Little, Brown & Co.
- Zanetti R, Crosignani P, Rosso S (1997) Cancer in Italy — Incidence Data from Cancer Registries, vol. 2: 1988–1992. Torino: Il Pensiero Scientifico Editore, p. 85.
- Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 211: 277-287.
- Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G (1996) Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicenter study. Eur J Gastroenterol Hepatol 8: 685-691.
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Metadata
- Authors
- Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G.
- Affiliations
- University of Brescia (IT)
- University of Milan (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Ospedale Sant'Orsola di Brescia (IT)
- Corresponding author
- Donato, Francesco
- Venue
- Cancer Causes & Control
- Published
- 2001-12
- Volume
- 12
- Issue
- 10
- Pages
- 959-964
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W1502967669
- Cited by
- 247
- References
- 48
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 4 · 2019: 12 · 2018: 12 · 2017: 11 · 2016: 10 · 2015: 14 · 2014: 15 · 2013: 18 · 2012: 18
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cancer Causes & Control (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- intrahepatic cholangiocarcinoma, hepatitis C virus, hepatitis B virus, HBsAg seropositivity, anti-HCV seropositivity, alcohol consumption, hepatolithiasis, primary liver cancer, risk factors, liver cirrhosis, Brescia
- MeSH terms
- Aged, Aged, 80 and over, Alcohol Drinking, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Female, Hepatitis B, Hepatitis C, Humans, Italy, Liver Cirrhosis, Liver Neoplasms, Male, Middle Aged, Risk Factors, Prevalence, Case-Control Studies, Cholangiocarcinoma, Lithiasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.